Search Results - "Andersen, Janet W"

Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration by Haas, David W., Bartlett, John A., Andersen, Janet W., Sanne, Ian, Wilkinson, Grant R., Hinkle, John, Rousseau, Franck, Ingram, Christiana D., Shaw, Audrey, Lederman, Michael M., Kim, Richard B.

“…Associations have been reported between an MDR1 variant and responses to nonnucleoside reverse-transcriptase inhibitors. We explored associations between MDR1,…”
Get full text

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection by Chew, Kara W., Hua, Lei, Bhattacharya, Debika, Butt, Adeel A., Bornfleth, Lorelei, Chung, Raymond T., Andersen, Janet W., Currier, Judith S.

“…Background.  Successful hepatitis C virus (HCV) treatment may reduce cardiovascular disease (CVD) risk and improve levels of CVD biomarkers produced outside…”
Get full text

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention by Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Andersen, Janet W., Mwelase, Thando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Kim, Peter, Fletcher, Courtney V.

“…Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs. We studied the…”
Get full text

Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE: Timing, Severity, and Implications for HIV–TB Programs by Luetkemeyer, Anne F, Kendall, Michelle A, Nyirenda, Mulinda, Wu, Xingye, Ive, Prudence, Benson, Constance A, Andersen, Janet W, Swindells, Susan, Sanne, Ian M, Havlir, Diane V, Kumwenda, Johnstone

“…RATIONALE AND OBJECTIVES:Earlier initiation of antiretroviral therapy (ART) in HIV–tuberculosis (TB) is associated with increased immune reconstitution…”
Get full text

Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy by Benson, Constance A, Andersen, Janet W, Macatangay, Bernard J C, Mailliard, Robbie B, Rinaldo, Charles R, Read, Sarah, Bozzolo, Dawn R, Purdue, Lynette, Jennings, Cheryl, Keefer, Michael C, Glesby, Marshall, Tebas, Pablo, Russell, Amy Falk, Martin, Jason, Annunziato, Paula, Popmihajlov, Zoran, Lennox, Jeffrey L

“…Live attenuated herpes zoster vaccine administered to HIV-infected adults suppressed on antiretroviral therapy with CD4+ counts ≥200 cells/µL was generally…”
Get full text

Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment by LEI HUA, ANDERSEN, Janet W, DAAR, Eric S, GLESBY, Marshall J, HOLLABAUGH, Kimberly, TIERNEY, Camlin

“…To explore the relationship between hepatitis C virus (HCV)/HIV coinfection and responses to initial antiretroviral treatment (ART). Four AIDS Clinical Trials…”
Get full text

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol by Tallman, Martin S., Andersen, Janet W., Schiffer, Charles A., Appelbaum, Frederick R., Feusner, James H., Woods, William G., Ogden, Angela, Weinstein, Howard, Shepherd, Lois, Willman, Cheryl, Bloomfield, Clara D., Rowe, Jacob M., Wiernik, Peter H.

“…We previously reported a benefit for all-trans retinoic acid (ATRA) in both induction and maintenance therapy in patients with acute promyelocytic leukemia…”
Get full text

Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV—Coinfected Persons: The AIDS Clinical Trials Group A5178 Study by Butt, Adeel A., Umbleja, Triin, Andersen, Janet W., Sherman, Kenneth E., Chung, Raymond T.

“…Background. The effect of peginterferon alpha/ribavirin (PEG-IFN/RBV) and hepatitis C virus (HCV) clearance on lipid and insulin resistance (IR) profiles in…”
Get full text

Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy by Fife, Kenneth H, Wu, Julia W, Squires, Kathleen E, Watts, D Heather, Andersen, Janet W, Brown, Darron R

“…OBJECTIVE:To determine the prevalence of human papillomavirus (HPV) DNA in cervical specimens from treatment-naive women initiating highly active…”
Get full text

Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C) by SHERMAN, Kenneth E, ANDERSEN, Janet W, BUTT, Adeel A, UMBLEJA, Triin, ALSTON, Beverly, KOZIEL, Margaret J, PETERS, Marion G, SULKOWSKI, Mark, GOODMAN, Zachary D, CHUNG, Raymond T

“…Hepatitis C virus (HCV)/HIV coinfection treatment is suboptimal with low sustained viral response rates to standard therapies. A multicenter randomized…”
Get full text

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia by Tallman, Martin S, Andersen, Janet W, Schiffer, Charles A, Appelbaum, Frederick R, Feusner, James H, Ogden, Angela, Shepherd, Lois, Willman, Cheryl, Bloomfield, Clara D, Rowe, Jacob M, Wiernik, Peter H

“…Acute promyelocytic leukemia is a distinct subtype of acute myeloid leukemia 1 in which a balanced reciprocal translocation between chromosomes 15 and 17…”
Get full text

Predictors of Antiretroviral-Related Hepatotoxicity in the Adult AIDS Clinical Trial Group (1989-1999) by Servoss, Julie C, Kitch, Douglas W, Andersen, Janet W, Reisler, Ronald B, Chung, Raymond T, Robbins, Gregory K

“…HIV antiretroviral therapy (ART)-related hepatotoxicity is a significant clinical problem, resulting in severe elevations of liver enzymes and, potentially,…”
Get full text

Factors associated with early study discontinuation in AACTG studies, DACS 200 by Andersen, Janet W, Fass, Robert, van der Horst, Charles

“…Abstract Background: When participants in a clinical trial are lost to follow-up, the validity of the results and resource utilization may be seriously…”
Get full text

Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084 by Cohn, Susan E, Umbleja, Triin, Mrus, Joseph, Bardeguez, Arlene D, Andersen, Janet W, Chesney, Margaret A

“…Adherence to antiretroviral therapy (ART) in pregnancy is crucial to optimize its efficacy and minimize mother-to-child transmission. Our objective was to…”
Get more information

A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207 by Kendall, Michelle A., Andersen, Janet W., van der Horst, Charles

“…Most large clinical trials for human immunodeficiency virus (HIV) conducted at university medical centers require intensive real-time monitoring, with clinic…”
Get full text

Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma by Smalley, Richard V, Andersen, Janet W, Hawkins, Michael J, Bhide, Vandana, O'Connell, Michael J, Oken, Martin M, Borden, Ernest C

“…INTERFERON ALFA has been found to be an effective therapeutic agent in patients with low-grade non-Hodgkin's lymphoma. Early studies using both crude natural…”
Get full text

Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study by MacGregor, Rob Roy, Hafner, Richard, Wu, Julia W, Murphy, Robert L, Perlman, David C, Bermudez, Luiz E, Inderlied, Clark B, Picker, Louis J, Wallis, Robert S, Andersen, Janet W, Mahon, Laura F, Koletar, Susan L, Peterson, Dolores M

“…The clinical, microbiologic, and immunologic parameters in HIV-infected subjects first presenting with disseminated Mycobacterium avium complex (DMAC) were…”
Get more information

Interferon Alfa plus Chemotherapy for Non-Hodgkin's Lymphoma: Five-Year Follow-up by Smalley, Richard V, Andersen, Janet W

“…To the Editor: As we previously reported (November 5, 1992, issue), 1 interferon alfa, when added to a four-drug, doxorubicin-based chemotherapy regimen, is an…”
Get full text

Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients by Chung, Raymond T, Umbleja, Triin, Chen, Jennifer Y, Andersen, Janet W, Butt, Adeel A, Sherman, Kenneth E

“…It is unknown whether extended treatment with pegylated interferon (PEG) and weight-based ribavirin (WBR) results in higher rates of sustained viro-logic…”
Get more information

HCV/HIV Co-infection and Responses to Initial Antiretroviral Treatment by Hua, Lei, Andersen, Janet W., Daar, Eric S., Glesby, Marshall J., Hollabaugh, Kimberly, Tierney, Camlin

Get full text